Genicular Artery Embolization (GAE): Evidence & Safety
Genicular Artery Embolization (GAE) is a minimally invasive procedure increasingly used to relieve chronic knee pain caused by osteoarthritis. As interest in GAE grows, so does the body of clinical research evaluating its effectiveness, safety, and appropriate use.
This page reviews what current studies show about GAE, explains who benefits most, outlines known risks and limitations, and clarifies what happens if results are incomplete—so patients can make informed, evidence-based decisions.
For an overview of how the procedure itself works, see our full guide to Genicular Artery Embolization.
Is Genicular Artery Embolization FDA Approved?
Genicular Artery Embolization is performed using embolic materials that are FDA-cleared for other uses and have been used for many years in vascular and interventional radiology procedures. Using them for knee pain is off-label.
Off-label use means a physician is using a cleared device or approved medication for a use not listed on its FDA labeling. Doctors may do this when they judge it appropriate, but it means FDA hasn’t reviewed the procedure for this use. Many widely accepted procedures—including numerous minimally invasive vascular treatments—were initially performed off label.
GAE is performed by trained specialists using image-guided, catheter-based techniques. For patients deciding whether the procedure is appropriate, understanding the clinical evidence supporting GAE is just as important as understanding its regulatory status.

What Does the Clinical Evidence Show?

Pain Relief and Functional Improvement
Studies without a comparison group report large drops in knee pain. In a 40-patient US study, 68% had at least 50% improvement in both pain and symptom scores at 12 months. At 24 months, 47% of patients with follow-up data had at least 50% improvement in a knee symptom score. Trials against a sham (placebo) procedure are mixed: one small trial of 21 patients favored GAE, and two larger trials of 58 and 59 patients found no significant difference. A 2026 pooled analysis also found no significant difference from sham. The Society of Interventional Radiology’s 2026 statement supports GAE as an option for patients who have not improved with conservative care and calls for larger trials. GAE may help some patients, but how much of that benefit comes from the procedure itself is not settled.
Across pooled studies:
- Patients experienced substantial reductions in knee pain, commonly exceeding the minimum clinically important difference (MCID) used by clinicians to define real improvement.
- Average improvements often exceeded 30 points on validated outcome measures such as the VAS (Visual Analog Scale) and WOMAC index.
- Improvements were seen in pain, stiffness, mobility, and daily activity levels at 6 to 12 months after treatment.
These findings are supported by landmark publications such as Bagla et al. in the Journal of Vascular and Interventional Radiology, institutional research from NYU Langone, and recent large-scale meta-analyses evaluating GAE outcomes.
Patients interested in comparative outcomes may also want to review how GAE performs relative to other options, including GAE vs total knee replacement and GAE vs cortisone injections.
How Long Do GAE Results Last?
Available evidence suggests that GAE results are durable for most patients, with published follow-up extending up to two years.
- Most patients maintain meaningful symptom improvement over time.
- Only a small percentage require additional intervention:
- Repeat GAE in approximately 8% of patients
- Progression to total knee replacement in approximately 5% of patients within two years
For a deeper look at durability and expectations over time, see How long genicular artery embolization results last and success rates of GAE in treating knee pain

Who Is a Good Candidate for GAE?
Clinical evidence shows the best outcomes in patients with:

Mild to moderate knee osteoarthritis (Kellgren-Lawrence grades 1–3)

Persistent knee pain despite physical therapy, injections, or oral medications

Patients who are not ready for, medically unfit for, or prefer to avoid knee replacement surgery

Typically between the ages of 40 and 80
Who Should Not Undergo GAE?
GAE is not appropriate for every patient. Based on current evidence and clinical experience, GAE may not be recommended for individuals with:
- Advanced, bone-on-bone osteoarthritis (Kellgren-Lawrence grade 4)
- Significant joint instability or severe deformity
- Active joint or systemic infection
- Severe peripheral arterial disease affecting knee circulation
- Expectations that GAE will regenerate cartilage or permanently cure arthritis
Understanding candidacy is critical, and patients who are not ideal candidates may benefit from reviewing why some patients are not candidates for GAE.

Safety Profile and Known Risks
How Safe Is GAE?
Across multiple studies, GAE has demonstrated a favorable safety profile:
- Technical success rates of approximately 99.7%
- Most reported adverse events are minor, temporary, and self-limited
- Most reported events resolved, but studies are small, so rare problems can’t be ruled out
For patients concerned about the procedure experience itself, see Is GAE painful? A guide to comfort.
Potential Side Effects
Reported side effects are uncommon and generally mild:
- Temporary skin discoloration near the knee (approximately 11% of cases)
- Mild soreness or discomfort following the procedure
Less common reports include skin sores, small areas of bone damage seen on MRI, blood clots, reactions to contrast dye, and kidney problems.
What Happens If GAE Doesn’t Work?
Patient responses to GAE vary and generally fall into three categories:
Strong responders with significant, lasting pain relief
Partial responders with improvement but persistent symptoms
Non-responders, often due to advanced disease severity or anatomical factors
If GAE does not provide adequate relief, next steps may include:
Repeat embolization in selected cases
Continued non-surgical management
Surgical evaluation, including knee replacement when appropriate
We don’t have strong data on whether prior GAE changes knee replacement results. Patients weighing options can review GAE vs total knee replacement for comparative considerations.

Limitations of Current Research
While evidence supporting GAE continues to expand, important limitations remain:
- Many studies are single-arm or observational
- Large-scale randomized trials are still emerging
- Long-term structural effects on cartilage are not yet fully defined
Ongoing research aims to clarify durability beyond several years, refine patient selection, and compare GAE with other minimally invasive therapies.
For patients interested in ongoing developments, see the latest research on GAE.
- Summary: What the Evidence Tells Us
Current clinical evidence supports Genicular Artery Embolization as a promising, minimally invasive treatment for knee osteoarthritis-related pain in carefully selected patients. Studies without a comparison group report improvements in pain and function, but trials against a sham procedure are mixed, and GAE has not been shown to prevent or delay knee replacement.For a complete overview of the procedure, visit Genicular Artery Embolization.
- Medical Review & References
This page is based on peer-reviewed randomized controlled trials, multicenter studies, and systematic reviews published between 2023 and 2025, including:
– Bagla et al., Journal of Vascular and Interventional Radiology
– NYU Langone clinical research
– GAUCHO trial review articles
– Meta-analyses published via ScienceDirect and PubMed Central
We Strive to Maintain a 5-star Reputation
Dr. Fox is an outstanding surgeon. Him and his staff explains everything clearly which makes for a smoother process. I've recommended him to family and several close friends, and they've all had the same excellent experience. If you want top-tier expertise with genuine compassion, Dr. Fox is the best. Highly recommend!
I had a very positive experience at Fox Vein Care. The doctor took time to explain everything clearly and made me feel comfortable throughout the process. The staff was also friendly and helpful. Overall, I felt well taken care of and am happy with my results. Highly recommended!
I had a great experience at this doctor's office. The doctor treated me with genuine care and respect, was very patient, and took the time to truly listen to my concerns. He explained everything clearly and gave thoughtful, helpful advice. I never felt rushed, and I left feeling confident and well taken care of. Highly recommend.
Dr. Fox is outstanding. He explains everything patiently and well. His staff is both efficient and kind. I wouldn't go anywhere else for vascular issues.
I have been a patient of Dr. Fox since he was at Roosevelt Hospital on 59th Street in Manhattan. He's the best, hands down! And his Staff are the best at what they do, along with excellent bedside manners. Crystal is the Greatest!
Schedule a Consultation at Our Manhattan Vein Treatment Center
If you’re looking for a vein specialist near you or a trusted vein treatment center in Manhattan, NY, Fox Vein Care is here to help. Schedule your vein consultation today and take the first step toward healthier legs.
We Accept Most Insurances
We work with most major insurance providers, but many don’t cover embolization for joint pain. Contact us to check your plan.
When to get help
Call 911 or go to the nearest emergency room right away if you have: sudden chest pain or trouble breathing; a suddenly cold, pale, blue, numb or very painful arm, hand, leg or foot; bleeding from a puncture site that does not stop with firm pressure; signs of stroke; or swelling of the face or throat. Don’t wait to call our office first.
Call us the same day for: new swelling in one leg, fever, spreading redness, a skin patch that darkens or blisters, or pain that is getting worse instead of better.
